Dynamic Technology Lab Private LTD Protagonist Therapeutics, Inc Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $127,111 - $189,374	16,172 Added 93.34%	33,498 $282,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $25.52 $12,820 - $46,344	1,816 Added 11.71%	17,326 $137,000
Q1 2022 May 16, 2022	BUY	$23.34 - $36.08 $362,003 - $559,600	15,510 New	15,510 $367,000
Q2 2021 Aug 13, 2021	SELL	$25.57 - $44.88 $209,725 - $368,105	-8,202 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.02 - $31.15 $37,279 - $61,054	-1,960 Reduced 19.29%	8,202 $212,000
Q4 2020 Feb 11, 2021	BUY	$18.49 - $25.13 $187,895 - $255,371	10,162 New	10,162 $205,000
Q1 2018 May 14, 2018	SELL	$8.46 - $23.08 $96,130 - $262,258	-11,363 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$14.47 - $20.8 $164,422 - $236,350	11,363	11,363 $236,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.